Frontlight ResearchEarly access
Trial site
Grand Teton Research Group
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis5 trials
- Crohn's disease2 trials
- Obesity2 trials
- Eosinophilic oesophagitis1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Status
- Active, not recruiting3 trials
- Recruiting3 trials
- Completed2 trials
- Lead sponsor
- Eli Lilly and Company7 trials
- Phathom Pharmaceuticals, Inc.1 trial
Running trials
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Ulcerative colitis2 recruiting
- Crohn's disease1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026